Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now includes a new revision label v3.6.5, replacing the previous v3.6.4 in the list.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision label v3.6.4 was added to the study record history. The previous revision label v3.6.3 was removed from the history list.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.3 was added to the history, and the previous v3.6.2 entry was removed, indicating an update to the study record.SummaryDifference0.1%

- Check64 days agoChange DetectedA newer revision (v3.6.2) was added to the study record history, and an older revision (v3.6.0) was removed, updating the version history.SummaryDifference0.1%

- Check78 days agoChange DetectedRecruitment status shows the study is no longer seeking participants, reflecting the current enrollment status. The record history updates to Revision: v3.6.0, superseding the prior Revision: v3.5.5 entry.SummaryDifference0.4%

- Check85 days agoChange DetectedThe record history shows a new latest revision tag v3.5.5 was added. The previous v3.5.4 tag was removed.SummaryDifference0.1%

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.